Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JRH Biosciences
Lenexa, Kansas, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
JRH Biosciences was a leading global supplier of cell culture products and services to the biopharmaceutical and diagnostic industries. The company specialized in the development and manufacture of serum-free media, fetal bovine serum (FBS), and other reagents essential for the production of biotherapeutics and vaccines. Known for its proprietary EX-CELL line of serum-free media, JRH provided critical raw materials and technical support for large-scale cell culture processes. In 2005, the company was acquired by Sigma-Aldrich to strengthen its fine chemicals division, SAFC, and it has since been integrated into MilliporeSigma, the life science business of Merck KGaA.
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on JRH Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JRH Biosciences.